{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T21:15:11Z","timestamp":1762982111072,"version":"3.40.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02513-7","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T07:02:05Z","timestamp":1745650925000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Establishment and validation of a novel prognostic nomogram for gallbladder cancer patients"],"prefix":"10.1186","volume":"30","author":[{"given":"Rongqiang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenxuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yankun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianguo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weixing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,26]]},"reference":[{"issue":"2","key":"2513_CR1","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.suc.2018.12.008","volume":"99","author":"L Hickman","year":"2019","unstructured":"Hickman L, Contreras C. Gallbladder cancer: diagnosis, surgical management, and adjuvant therapies. Surg Clin North Am. 2019;99(2):337\u201355. https:\/\/doi.org\/10.1016\/j.suc.2018.12.008.","journal-title":"Surg Clin North Am"},{"issue":"1","key":"2513_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-022-00398-y","volume":"8","author":"JC Roa","year":"2022","unstructured":"Roa JC, Garcia P, Kapoor VK, Maithel SK, Javle M, Koshiol J. Gallbladder cancer. Nat Rev Dis Primers. 2022;8(1):69. https:\/\/doi.org\/10.1038\/s41572-022-00398-y.","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"2513_CR3","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ejso.2013.02.010","volume":"39","author":"M D'Hondt","year":"2013","unstructured":"D\u2019Hondt M, Lapointe R, Benamira Z, Pottel H, Plasse M, Letourneau R, et al. Carcinoma of the gallbladder: patterns of presentation, prognostic factors and survival rate. An 11-year single centre experience. Eur J Surg Oncol. 2013;39(6):548\u201353. https:\/\/doi.org\/10.1016\/j.ejso.2013.02.010.","journal-title":"Eur J Surg Oncol"},{"key":"2513_CR4","doi-asserted-by":"publisher","first-page":"1183619","DOI":"10.3389\/fphar.2023.1183619","volume":"14","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Yuan K, Yang Y, Ji Z, Zhou D, Ouyang J, et al. Gallbladder cancer: current and future treatment options. Front Pharmacol. 2023;14:1183619. https:\/\/doi.org\/10.3389\/fphar.2023.1183619.","journal-title":"Front Pharmacol"},{"issue":"4 Pt A","key":"2513_CR5","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ejso.2019.10.015","volume":"46","author":"J Wang","year":"2020","unstructured":"Wang J, Bo X, Shi X, Suo T, Xin Y, Nan L, et al. Modified staging classification of gallbladder carcinoma on the basis of the 8(th) edition of the American Joint Commission on Cancer (AJCC) staging system. Eur J Surg Oncol. 2020;46(4 Pt A):527\u201333. https:\/\/doi.org\/10.1016\/j.ejso.2019.10.015.","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"2513_CR6","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3390\/cancers13030547","volume":"13","author":"D Giannis","year":"2021","unstructured":"Giannis D, Cerullo M, Moris D, Shah KN, Herbert G, Zani S, et al. Validation of the 8th Edition American Joint Commission on Cancer (AJCC) gallbladder cancer staging system: prognostic discrimination and identification of key predictive factors. Cancers (Basel). 2021;13(3):547. https:\/\/doi.org\/10.3390\/cancers13030547.","journal-title":"Cancers (Basel)."},{"issue":"13","key":"2513_CR7","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1200\/JCO.2007.14.7934","volume":"26","author":"SJ Wang","year":"2008","unstructured":"Wang SJ, Fuller CD, Kim JS, Sittig DF, Thomas CR Jr, Ravdin PM. Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer. J Clin Oncol. 2008;26(13):2112\u20137. https:\/\/doi.org\/10.1200\/JCO.2007.14.7934.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2513_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/cam4.2679","volume":"9","author":"W Mao","year":"2020","unstructured":"Mao W, Deng F, Wang D, Gao L, Shi X. Treatment of advanced gallbladder cancer: a SEER-based study. Cancer Med. 2020;9(1):141\u201350. https:\/\/doi.org\/10.1002\/cam4.2679.","journal-title":"Cancer Med"},{"issue":"4","key":"2513_CR9","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173\u201380. https:\/\/doi.org\/10.1016\/S1470-2045(14)71116-7.","journal-title":"Lancet Oncol"},{"issue":"2","key":"2513_CR10","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.jtcvs.2016.10.019","volume":"153","author":"C Jin","year":"2017","unstructured":"Jin C, Cao J, Cai Y, Wang L, Liu K, Shen W, et al. A nomogram for predicting the risk of invasive pulmonary adenocarcinoma for patients with solitary peripheral subsolid nodules. J Thorac Cardiovasc Surg. 2017;153(2):462-9e 1. https:\/\/doi.org\/10.1016\/j.jtcvs.2016.10.019.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"7","key":"2513_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/cac2.12067","volume":"40","author":"J Wu","year":"2020","unstructured":"Wu J, Zhang H, Li L, Hu M, Chen L, Xu B, et al. A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: a population-based analysis. Cancer Commun (Lond). 2020;40(7):301\u201312. https:\/\/doi.org\/10.1002\/cac2.12067.","journal-title":"Cancer Commun (Lond)"},{"issue":"10","key":"2513_CR12","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/sim.4154","volume":"30","author":"H Uno","year":"2011","unstructured":"Uno H, Cai T, Pencina MJ, D\u2019Agostino RB, Wei LJ. On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Stat Med. 2011;30(10):1105\u201317. https:\/\/doi.org\/10.1002\/sim.4154.","journal-title":"Stat Med"},{"issue":"2","key":"2513_CR13","doi-asserted-by":"publisher","first-page":"E260","DOI":"10.1208\/aapsj0902029","volume":"9","author":"JW Findlay","year":"2007","unstructured":"Findlay JW, Dillard RF. Appropriate calibration curve fitting in ligand binding assays. AAPS J. 2007;9(2):E260\u20137. https:\/\/doi.org\/10.1208\/aapsj0902029.","journal-title":"AAPS J"},{"key":"2513_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1472-6947-8-53","volume":"8","author":"AJ Vickers","year":"2008","unstructured":"Vickers AJ, Cronin AM, Elkin EB, Gonen M. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inform Decis Mak. 2008;8:53. https:\/\/doi.org\/10.1186\/1472-6947-8-53.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"3","key":"2513_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.otohns.2010.05.007","volume":"143","author":"JT Rich","year":"2010","unstructured":"Rich JT, Neely JG, Paniello RC, Voelker CC, Nussenbaum B, Wang EW. A practical guide to understanding Kaplan\u2013Meier curves. Otolaryngol Head Neck Surg. 2010;143(3):331\u20136. https:\/\/doi.org\/10.1016\/j.otohns.2010.05.007.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"6","key":"2513_CR16","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1002\/jso.27450","volume":"128","author":"S Vuthaluru","year":"2023","unstructured":"Vuthaluru S, Sharma P, Chowdhury S, Are C. Global epidemiological trends and variations in the burden of gallbladder cancer. J Surg Oncol. 2023;128(6):980\u20138. https:\/\/doi.org\/10.1002\/jso.27450.","journal-title":"J Surg Oncol"},{"key":"2513_CR17","doi-asserted-by":"publisher","first-page":"1159235","DOI":"10.3389\/fendo.2023.1159235","volume":"14","author":"H Zhou","year":"2023","unstructured":"Zhou H, Chen J, Jin H, Liu K. Genetic characteristics and clinical-specific survival prediction in elderly patients with gallbladder cancer: a genetic and population-based study. Front Endocrinol (Lausanne). 2023;14:1159235. https:\/\/doi.org\/10.3389\/fendo.2023.1159235.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2513_CR18","doi-asserted-by":"publisher","first-page":"6370946","DOI":"10.1155\/2020\/6370946","volume":"2020","author":"P Li","year":"2020","unstructured":"Li P, Song L. Prognostic evaluation for patients over 45 years old with gallbladder adenocarcinoma resection: a SEER-based nomogram analysis. Biomed Res Int. 2020;2020:6370946. https:\/\/doi.org\/10.1155\/2020\/6370946.","journal-title":"Biomed Res Int"},{"issue":"6","key":"2513_CR19","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2513_CR20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1172\/jci114977","volume":"87","author":"GT Everson","year":"1991","unstructured":"Everson GT, McKinley C, KernJr F. Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism. J Clin Invest. 1991;87(1):237\u201346. https:\/\/doi.org\/10.1172\/jci114977.","journal-title":"J Clin Invest"},{"issue":"14","key":"2513_CR21","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.7150\/jca.30046","volume":"10","author":"M Chen","year":"2019","unstructured":"Chen M, Cao J, Zhang B, Pan L, Cai X. A nomogram for prediction of overall survival in patients with node-negative gallbladder cancer. J Cancer. 2019;10(14):3246\u201352. https:\/\/doi.org\/10.7150\/jca.30046.","journal-title":"J Cancer"},{"issue":"7","key":"2513_CR22","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1245\/s10434-010-1468-3","volume":"18","author":"JL Gnerlich","year":"2011","unstructured":"Gnerlich JL, Deshpande AD, Jeffe DB, Seelam S, Kimbuende E, Margenthaler JA. Poorer survival outcomes for male breast cancer compared with female breast cancer may be attributable to in-stage migration. Ann Surg Oncol. 2011;18(7):1837\u201344. https:\/\/doi.org\/10.1245\/s10434-010-1468-3.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2513_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1046\/j.1365-2559.2003.01530.x","volume":"42","author":"S Matsukita","year":"2003","unstructured":"Matsukita S, Nomoto M, Kitajima S, Tanaka S, Goto M, Irimura T, et al. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma. Histopathology. 2003;42(1):26\u201336. https:\/\/doi.org\/10.1046\/j.1365-2559.2003.01530.x.","journal-title":"Histopathology"},{"key":"2513_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.175210","volume":"932","author":"M Abdel Rhman","year":"2022","unstructured":"Abdel Rhman M, Pmo O. Potential therapeutic applications of microRNAs in cancer diagnosis and treatment: sharpening a double-edged sword? Eur J Pharmacol. 2022;932: 175210. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175210.","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"2513_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.21037\/cco.2019.08.03","volume":"8","author":"U Dutta","year":"2019","unstructured":"Dutta U, Bush N, Kalsi D, Popli P, Kapoor VK. Epidemiology of gallbladder cancer in India. Chin Clin Oncol. 2019;8(4):33. https:\/\/doi.org\/10.21037\/cco.2019.08.03.","journal-title":"Chin Clin Oncol"},{"key":"2513_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2021.100431","volume":"28","author":"J Singh","year":"2021","unstructured":"Singh J, Shukla D, Gupta S, Shrivastav BR, Tiwari PK. Clinical epidemiology of gallbladder cancer in North-Central India and association of immunological markers, NLR, MLR and PLR in the diagnostic\/prognostic prediction of GBC. Cancer Treat Res Commun. 2021;28: 100431. https:\/\/doi.org\/10.1016\/j.ctarc.2021.100431.","journal-title":"Cancer Treat Res Commun"},{"key":"2513_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.puhe.2021.12.002","volume":"203","author":"C Nie","year":"2022","unstructured":"Nie C, Yang T, Liu L, Hong F. Trend analysis and risk of gallbladder cancer mortality in China, 2013\u20132019. Public Health. 2022;203:31\u20135. https:\/\/doi.org\/10.1016\/j.puhe.2021.12.002.","journal-title":"Public Health"},{"issue":"2","key":"2513_CR28","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.amjsurg.2007.11.011","volume":"196","author":"S Gourgiotis","year":"2008","unstructured":"Gourgiotis S, Kocher HM, Solaini L, Yarollahi A, Tsiambas E, Salemis NS. Gallbladder cancer. Am J Surg. 2008;196(2):252\u201364. https:\/\/doi.org\/10.1016\/j.amjsurg.2007.11.011.","journal-title":"Am J Surg"},{"issue":"4","key":"2513_CR29","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.4103\/jcrt.JCRT_646_19","volume":"18","author":"M Sharma","year":"2022","unstructured":"Sharma M, Rath A, Tomar R, Khurana N, Ghuliani D. Mucinous carcinoma of the gallbladder- two rare case reports. J Cancer Res Ther. 2022;18(4):1192\u20134. https:\/\/doi.org\/10.4103\/jcrt.JCRT_646_19.","journal-title":"J Cancer Res Ther"},{"issue":"2\u20133","key":"2513_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1385\/ijgc:34:2-3:151","volume":"34","author":"SA Spector","year":"2003","unstructured":"Spector SA, Fernandez VE, Vernon SE, Dunkin B, Livingstone AS. Gallbladder cystadenoma and common bile duct obstruction. Int J Gastrointest Cancer. 2003;34(2\u20133):151\u20135. https:\/\/doi.org\/10.1385\/ijgc:34:2-3:151.","journal-title":"Int J Gastrointest Cancer"},{"issue":"11","key":"2513_CR31","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.5858\/arpa.2011-0447-OA","volume":"136","author":"N Dursun","year":"2012","unstructured":"Dursun N, Escalona OT, Roa JC, Basturk O, Bagci P, Cakir A, et al. Mucinous carcinomas of the gallbladder: clinicopathologic analysis of 15 cases identified in 606 carcinomas. Arch Pathol Lab Med. 2012;136(11):1347\u201358. https:\/\/doi.org\/10.5858\/arpa.2011-0447-OA.","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"2513_CR32","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.2214\/ajr.165.5.7572497","volume":"165","author":"LA Wibbenmeyer","year":"1995","unstructured":"Wibbenmeyer LA, Sharafuddin MJ, Wolverson MK, Heiberg EV, Wade TP, Shields JB. Sonographic diagnosis of unsuspected gallbladder cancer: imaging findings in comparison with benign gallbladder conditions. AJR Am J Roentgenol. 1995;165(5):1169\u201374. https:\/\/doi.org\/10.2214\/ajr.165.5.7572497.","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"2513_CR33","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0899-7071(95)00034-8","volume":"20","author":"M Pandey","year":"1996","unstructured":"Pandey M, Khatri AK, Sood BP, Shukla RC, Shukla VK. Cholecystosonographic evaluation of the prevalence of gallbladder diseases. A university hospital experience. Clin Imaging. 1996;20(4):269\u201372. https:\/\/doi.org\/10.1016\/0899-7071(95)00034-8.","journal-title":"Clin Imaging"},{"issue":"8","key":"2513_CR34","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1007\/s00330-002-1440-0","volume":"12","author":"V Kumaran","year":"2002","unstructured":"Kumaran V, Gulati S, Paul B, Pande K, Sahni P, Chattopadhyay K. The role of dual-phase helical CT in assessing resectability of carcinoma of the gallbladder. Eur Radiol. 2002;12(8):1993\u20139. https:\/\/doi.org\/10.1007\/s00330-002-1440-0.","journal-title":"Eur Radiol"},{"issue":"4","key":"2513_CR35","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1016\/j.suronc.2012.08.002","volume":"21","author":"C Boutros","year":"2012","unstructured":"Boutros C, Gary M, Baldwin K, Somasundar P. Gallbladder cancer: past, present and an uncertain future. Surg Oncol. 2012;21(4):e183\u201391. https:\/\/doi.org\/10.1016\/j.suronc.2012.08.002.","journal-title":"Surg Oncol"},{"issue":"9","key":"2513_CR36","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1097\/JS9.0000000000000510","volume":"109","author":"ZP Liu","year":"2023","unstructured":"Liu ZP, Guo W, Yin DL, Chen WY, Wang JY, Li XL, et al. Textbook outcomes in liver surgery for gallbladder cancer patients treated with curative-intent resection: a multicenter observational study. Int J Surg. 2023;109(9):2751\u201361. https:\/\/doi.org\/10.1097\/JS9.0000000000000510.","journal-title":"Int J Surg"},{"issue":"14","key":"2513_CR37","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362(14):1273\u201381. https:\/\/doi.org\/10.1056\/NEJMoa0908721.","journal-title":"N Engl J Med"},{"issue":"5","key":"2513_CR38","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/S1470-2045(21)00027-9","volume":"22","author":"A Lamarca","year":"2021","unstructured":"Lamarca A, Palmer DH, Wasan HS, Ross PJ, Ma YT, Arora A, et al. Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial. Lancet Oncol. 2021;22(5):690\u2013701. https:\/\/doi.org\/10.1016\/S1470-2045(21)00027-9.","journal-title":"Lancet Oncol"},{"issue":"1","key":"2513_CR39","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S2468-1253(22)00335-1","volume":"8","author":"CK Lee","year":"2023","unstructured":"Lee CK, Chon HJ, Cheon J, Lee MA, Im HS, Jang JS, et al. Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19-14). Lancet Gastroenterol Hepatol. 2023;8(1):56\u201365. https:\/\/doi.org\/10.1016\/S2468-1253(22)00335-1.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2513_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.604387","volume":"10","author":"E Gkika","year":"2020","unstructured":"Gkika E, Hawkins MA, Grosu AL, Brunner TB. The evolving role of radiation therapy in the treatment of biliary tract cancer. Front Oncol. 2020;10: 604387. https:\/\/doi.org\/10.3389\/fonc.2020.604387.","journal-title":"Front Oncol"},{"issue":"1","key":"2513_CR41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13014-020-1459-x","volume":"15","author":"B Ren","year":"2020","unstructured":"Ren B, Guo Q, Yang Y, Liu L, Wei S, Chen W, et al. A meta-analysis of the efficacy of postoperative adjuvant radiotherapy versus no radiotherapy for extrahepatic cholangiocarcinoma and gallbladder carcinoma. Radiat Oncol. 2020;15(1):15. https:\/\/doi.org\/10.1186\/s13014-020-1459-x.","journal-title":"Radiat Oncol"},{"issue":"1","key":"2513_CR42","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12885-020-6610-4","volume":"20","author":"TO Goetze","year":"2020","unstructured":"Goetze TO, Bechstein WO, Bankstahl US, Keck T, Konigsrainer A, Lang SA, et al. Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC\/ECC)\u2014a phase III study of the German registry of incidental gallbladder carcinoma platform (GR)\u2014the AIO\/CALGP\/ACO-GAIN-trial. BMC Cancer. 2020;20(1):122. https:\/\/doi.org\/10.1186\/s12885-020-6610-4.","journal-title":"BMC Cancer"},{"issue":"4","key":"2513_CR43","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1002\/jso.26389","volume":"123","author":"JX Xiang","year":"2021","unstructured":"Xiang JX, Zhang XF, Weber SM, Poultsides G, Fields RC, Hatzaras I, et al. Identification of patients who may benefit the most from adjuvant chemotherapy following resection of incidental gallbladder carcinoma. J Surg Oncol. 2021;123(4):978\u201385. https:\/\/doi.org\/10.1002\/jso.26389.","journal-title":"J Surg Oncol"},{"issue":"5","key":"2513_CR44","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1590\/S1677-5538.IBJU.2022.0091.1","volume":"48","author":"E Mazzucchi","year":"2022","unstructured":"Mazzucchi E. Both the nomogram and the score system can represent an useful tool especially in those cases where the complication is foreseen by the surgeon. Int Braz J Urol. 2022;48(5):828\u20139. https:\/\/doi.org\/10.1590\/S1677-5538.IBJU.2022.0091.1.","journal-title":"Int Braz J Urol"},{"issue":"1","key":"2513_CR45","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/cam4.4442","volume":"11","author":"J Xiao","year":"2022","unstructured":"Xiao J, Zhou R, Zhang B, Li B. Noninvasive preoperative differential diagnosis of gallbladder carcinoma and xanthogranulomatous cholecystitis: a retrospective cohort study of 240 patients. Cancer Med. 2022;11(1):176\u201382. https:\/\/doi.org\/10.1002\/cam4.4442.","journal-title":"Cancer Med"},{"key":"2513_CR46","doi-asserted-by":"publisher","first-page":"1355927","DOI":"10.3389\/fonc.2024.1355927","volume":"14","author":"T Fu","year":"2024","unstructured":"Fu T, Bao Y, Zhong Z, Gao Z, Ye T, Zhang C, et al. Machine learning-based diagnostic model for preoperative differentiation between xanthogranulomatous cholecystitis and gallbladder carcinoma: a multicenter retrospective cohort study. Front Oncol. 2024;14:1355927. https:\/\/doi.org\/10.3389\/fonc.2024.1355927.","journal-title":"Front Oncol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02513-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02513-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02513-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T07:02:05Z","timestamp":1745650925000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02513-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,26]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2513"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02513-7","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,26]]},"assertion":[{"value":"7 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"331"}}